CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Open-market sale Chief Corp. Affairs Officer sold 18,000 shares at $17.72 ($319,010)
- 4 Open-market sale President and CEO sold 175,000 shares at $18.00 ($3,150,053)
- 4 Open-market sale SVP & General Counsel sold 5,600 shares at an average $17.85 ($99,966)
- 4 Open-market sale SVP & General Counsel sold 19,530 shares at an average $18.58 ($362,850)
- 4 Open-market sale SVP, Chief Marketing Officer sold 3,888 shares at $18.45 ($71,729)
- 4 Open-market sale President and CEO sold 22,685 shares at an average $18.38 ($416,905)
- 4 Open-market sale SVP, CFO & Treasurer sold 9,371 shares at an average $18.35 ($171,971)
- 4 Open-market sale Chief Corp. Affairs Officer sold 3,865 shares at $18.04 ($69,717)
- 4 Open-market sale SVP, Business Development sold 20,465 shares at an average $18.28 ($374,017)
- 4 Grant or award SVP & General Counsel acquired 32,700 shares (grant or award)
- 4 Grant or award SVP, Chief Marketing Officer acquired 25,800 shares (grant or award)
- 4 Grant or award President and CEO acquired 115,000 shares (grant or award)
- 4 Grant or award SVP, CFO & Treasurer acquired 32,700 shares (grant or award)
- 4 Open-market sale Chief Corp. Affairs Officer sold 22,986 shares at $20.01 ($460,033)
- 4 Grant or award SVP, Business Development acquired 32,700 shares (grant or award)
- 4 Open-market sale Director sold 5,818 shares at $18.54 ($107,856)
- 4 Open-market sale Director sold 5,754 shares at $18.54 ($106,663)
Page 7 of 29 · 579 filings